Lyrus

We're proud to share that Elayaraja Natarajan, VP of R&D at Lyrus Life sciences Pvt. Ltd, participated in a thought-provoking panel discussion at the 2024 on June 21st. The panel, titled 'Navigating India Pharma Inc's challenges and opportunities', brought together industry leaders to discuss key trends shaping our sector.

Key takeaways from the discussion:

1. Technology transfer remains complex, facing challenges in scale, consistency, and regulatory compliance.

2. Digital technologies, including AI/ML, are revolutionizing pharma processes across manufacturing, R&D, and regulatory filing.

3. Pharmaceutical packaging is evolving rapidly, driven by new materials, technologies, and sustainability demands.

4. Supply chain traceability is crucial for ensuring product safety and efficacy.

5. The industry is increasingly focusing on sustainability and ESG initiatives.

We're committed to driving innovation at Lyrus, and forums like this help us stay at the forefront of industry developments. Thanks to CILICANT and Ami Polymer for organizing this valuable event.

World Blood Donor Day - Recognising the Vital Role of Safe Blood Supplies

On this World Blood Donor Day, we extend our gratitude to the selfless individuals who donate blood regularly. Your acts of generosity help replenish blood supplies, enabling vital medical treatments and playing a crucial role in saving countless lives worldwide.

We also commend the dedication of healthcare professionals, blood banks, and organisations working tirelessly to ensure blood safety, proper screening, and efficient distribution. Their efforts are instrumental in maintaining a robust blood supply chain.

At Lyrus, we are proud to collaborate with partners who share our commitment to quality and patient safety. Together, we strive to advance the development of innovative therapies that contribute to improved health outcomes globally.

Let us celebrate World Blood Donor Day by raising awareness of the ongoing need for blood donations and recognising the invaluable contributions of voluntary unpaid blood donors everywhere.

Embracing Environmental Sustainability at Lyrus:
At Lyrus, we take immense pride in our commitment to environmental stewardship. As a leading CDMO, we understand the vital role we play in safeguarding our planet for future generations. On this World Environment Day, we reaffirm our dedication to sustainable practices throughout our operations.
Our state-of-the-art manufacturing facilities are designed to minimize our environmental footprint. We continuously invest in energy-efficient technologies, water conservation measures, and waste reduction initiatives. Through our comprehensive environmental management system, we meticulously monitor and mitigate our impact on air, water, and soil.
Beyond our facilities, we actively promote sustainable practices among our employees and partners. We encourage the adoption of eco-friendly commuting options, support local community environmental initiatives, and collaborate with like-minded organizations to drive positive change.
At Lyrus, we believe that environmental responsibility goes hand in hand with delivering high-quality products and services to our clients. By integrating sustainability into every aspect of our operations, we not only contribute to a healthier planet but also foster innovation and long-term business success.
Join us in celebrating World Environment Day and embracing a greener future for all. Together, we can make a lasting difference.

As the world observes World No To***co Day, Lyrus stands in solidarity with the global efforts to raise awareness about the harmful effects of to***co consumption and promote a to***co-free lifestyle.

To***co use is a major public health concern, contributing to numerous preventable diseases, including various types of cancer, cardiovascular diseases, and respiratory illnesses. At Lyrus, we understand the significant burden to***co-related illnesses place on individuals, families, and healthcare systems worldwide.

On this World No To***co Day, Lyrus reaffirms its commitment to being a catalyst for change in the fight against to***co-related health issues. We stand alongside healthcare professionals, advocacy groups, and individuals worldwide, united in our efforts to raise awareness, promote to***co cessation, and improve the lives of those affected by to***co-related illnesses.

***coDay ***coFree

On World Thyroid Day, Lyrus joins the global community in raising awareness about thyroid disorders and their impact on individuals worldwide.
The thyroid gland plays a crucial role in regulating various bodily functions, including metabolism, growth, and development. Thyroid disorders, such as hypothyroidism, hyperthyroidism, and thyroid cancer, can significantly affect an individual's overall health and well-being if left undiagnosed or untreated.
At Lyrus, we understand the importance of addressing thyroid-related conditions through innovative and effective treatments. Our team of experts collaborates closely with pharmaceutical companies, leveraging our extensive capabilities in drug development and manufacturing to advance the innovations and production of thyroid medications.
Our state-of-the-art facilities and cutting-edge technologies enable us to tackle the complexities involved in developing and manufacturing thyroid therapies. From formulation development to commercial-scale production, we ensure strict adherence to quality standards and regulatory guidelines, ensuring the highest levels of safety and efficacy for patients.
Furthermore, we recognise the need for patient-centric approaches in managing thyroid disorders. Our expertise in drug delivery systems and formulation development allows us to contribute to improved patient adherence and better treatment outcomes, ultimately enhancing the quality of life for those affected.
On this World Thyroid Day, Lyrus reaffirms its commitment to supporting the global healthcare community in addressing the challenges posed by thyroid disorders. Together, we can raise awareness, promote early detection, and facilitate access to effective treatments, making a meaningful difference in the lives of millions of people worldwide.


Stabicon Life Sciences Pvt. Ltd. Lyrus Life sciences Pvt. Ltd

Today, on World Autoimmune Arthritis Day, Lyrus stands in solidarity with the millions of individuals worldwide affected by autoimmune forms of arthritis, such as rheumatoid arthritis, psoriatic arthritis, and lupus.

Autoimmune arthritis is a debilitating condition that can significantly impact a person's quality of life, causing chronic pain, joint inflammation, and potential disability. At Lyrus, we understand the immense burden these conditions place on patients and their loved ones, and we are committed to supporting the development of innovative therapies to alleviate their suffering.

Through our drug development and manufacturing capabilities, we collaborate closely with our pharmaceutical partners to advance the development and production of cutting-edge treatments for autoimmune arthritis. Our highly skilled scientists, researchers, and manufacturing experts work tirelessly to ensure the highest standards of quality, safety, and efficacy in every step of the process.
Our state-of-the-art facilities and cutting-edge technologies enable us to tackle the complex challenges associated with these conditions.

On this World Autoimmune Arthritis Day, Lyrus reaffirms its commitment to being a catalyst for change in the fight against autoimmune arthritis. We stand alongside patients, healthcare professionals, and advocacy groups, united to raise awareness, promote early diagnosis, and facilitate access to effective treatments worldwide.

On World Hypertension Day, Lyrus, a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO), would like to raise awareness about the global burden of hypertension, also known as high blood pressure.
Hypertension is a major risk factor for cardiovascular diseases, such as heart attacks, strokes, and heart failure, which are among the leading causes of death worldwide. According to the World Health Organization (WHO), approximately 1.28 billion adults aged 30-79 years worldwide have hypertension.
At Lyrus, we recognize the critical importance of addressing this global health challenge. Through our comprehensive range of services, including formulation development and manufacturing, we are committed to supporting our pharmaceutical partners in developing innovative and effective treatments for hypertension and its associated complications.
Our team of experts collaborates closely with our clients, leveraging our state-of-the-art facilities and cutting-edge technologies to advance the development of antihypertensive medications. From development to commercial manufacturing, we ensure strict adherence to quality standards and regulatory guidelines.
Furthermore, we understand the importance of patient-centric approaches in managing hypertension. Our expertise in formulation development and drug delivery systems enables us to contribute to improved patient adherence and better treatment outcomes.
On this World Hypertension Day, Lyrus reaffirms its commitment to supporting the global healthcare community in addressing this silent killer. Together, we can raise awareness, promote early detection, and facilitate access to effective treatments, ultimately improving the lives of millions of people affected by hypertension worldwide.


Stabicon Rnd Lab Lyrus

Today, on International Nurses Day, we at Lyrus would like to express our sincere gratitude and admiration for the dedicated nurses around the world. These healthcare heroes are the backbone of our healthcare systems, providing compassionate care and support to patients and their families during their most vulnerable moments.

Nurses are the ones who spend countless hours at the bedside, offering not only medical expertise but also emotional support and a comforting presence. They are the ones who hold our hands, wipe our tears, and inspire us with their unwavering resilience and strength.

In the pharmaceutical industry, we understand the vital role nurses play in ensuring the safe and effective administration of medications. Their knowledge, attention to detail, and commitment to patient well-being are invaluable in achieving positive treatment outcomes.

On International Nurses Day, we salute the tireless efforts of nurses worldwide. Their selfless dedication, professionalism, and empathy are truly inspiring.

Thank you, nurses, for your unwavering commitment to healing and nurturing. Your care and compassion touch countless lives, and your impact extends far beyond the hospital walls.

🧼 Clean Hands Save Lives: Celebrating Hand Hygiene Day 2024

At Lyrus, we are proud to join the global healthcare community in observing Hand Hygiene Day on May 5th. As a leading pharmaceutical contract development and manufacturing organisation (CDMO), we understand the critical role proper hand hygiene plays in preventing the spread of infections and protecting public health.

Why is sharing knowledge about hand hygiene still so important? Because it helps stop the spread of harmful germs in health care. At Lyrus, we maintain the highest standards of hand hygiene across our facilities to ensure the safety and quality of the products we develop and manufacture for our clients.

On this Hand Hygiene Day, we reaffirm our commitment to:

✅ Rigorous hand hygiene protocols for all employees
✅ Regular training and education on proper hand-washing techniques
✅ Providing easily accessible hand hygiene stations throughout our facilities
✅ Collaborating with clients to promote hand hygiene awareness
✅ Supporting global initiatives to improve hand hygiene practices

Join us in celebrating Hand Hygiene Day and promoting the life-saving power of clean hands! Together, we can unite for safety and create a healthier world. 🌍🤝

Today, we join the nation in celebrating Ayushman Bharat Diwas and the transformative impact of the Ayushman Bharat Yojana on India's healthcare landscape. As a leading CDMO, is committed to supporting the Government's vision of universal health coverage by leveraging our expertise to make quality healthcare accessible and affordable for all. On this day, we reaffirm our dedication to developing and manufacturing innovative, cost-effective solutions that align with the Ayushman Bharat mission. Together, let us strive to create a healthier, more equitable India where no one is left behind. 🇮🇳❤️

Today, on World Malaria Day, we recognize the global fight against this deadly disease. As a CDMO, Lyrus is proud to support our clients in developing and manufacturing critical antimalarial drugs to help combat malaria worldwide. We are committed to leveraging our expertise to accelerate the delivery of these life-saving treatments to the communities that need them most. On this day, let us remember the millions of lives impacted by malaria and reaffirm our dedication to ending this epidemic. Together, through innovative science, partnership, and unwavering resolve, we can strive for a world free from malaria. 🦟💉

Today, on World Earth Day, let's reflect on how each of us can be better stewards of our planet. As a contract development and manufacturing organization (CDMO), is committed to implementing sustainable practices throughout our operations. From reducing waste and emissions to developing greener manufacturing processes for our clients, sustainability is a core part of how we do business. This Earth Day, I encourage everyone to consider what steps, big or small, you can take in your organization and personal life to help protect our environment for future generations. Together, we can make a meaningful, lasting impact. 🌎

On World Health Day 2024, Lyrus proudly stands with the global healthcare community in advocating for the fundamental right to health and well-being of all individuals. This year's theme, "My health, my right," underscores the importance of equitable access to quality healthcare services and our role in promoting and protecting our health.
As a leading Pharma CDMO, we recognize our responsibility to support this fundamental human right. Our mission is to collaborate with our partners to develop and manufacture innovative therapies that address the world's most pressing health challenges, ultimately improving patient lives worldwide. We believe everyone deserves access to safe, effective, and affordable medicines regardless of socioeconomic status or geographic location.
Lyrus is committed to leveraging our state-of-the-art facilities, cutting-edge technologies, and expert team to drive healthcare innovation and expand access to life-saving treatments. By partnering with pharmaceutical companies, we help bring ground-breaking therapies to market faster, ensuring that patients can benefit from the latest advancements in medical science.
On this World Health Day, we express our gratitude to the tireless efforts of healthcare professionals, researchers, and advocates who work diligently to promote health equity and protect the right to health for all. Together, we can build a world where everyone has the opportunity to lead healthy, fulfilling lives.
At Lyrus, we reaffirm our dedication to making a positive impact on global health, one patient at a time. Let us celebrate the progress we've made and renew our commitment to creating a future where "My health, my right" is a reality for all.
hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag
Stabicon Rnd Lab Stabicon Life Sciences Pvt. Ltd. Lyrus Life sciences Pvt. Ltd

Happy Holi to all our colleagues, partners, and friends! 🌈
At Lyrus, we believe in celebrating the vibrant colours of life, just like the festival of Holi. As a leading Pharmaceutical CDMO, we are committed to bringing the colours of health and wellness to people across the globe through our innovative solutions and dedicated services.
Holi is a time to come together, forgive, and renew our relationships. Similarly, we at Lyrus value our strong partnerships with our clients and their trust in us. We strive to foster collaboration, transparency, and mutual growth in all our engagements.
Just as Holi signifies the triumph of good over evil, we at Lyrus are committed to fighting against diseases and improving patient lives through our cutting-edge pharmaceutical development and manufacturing services. Our team of experts works tirelessly to ensure the highest quality standards and regulatory compliance in every project we undertake.
On this joyous occasion, we extend our warmest wishes to everyone celebrating Holi. May this festival bring abundant happiness, success, and new opportunities for all.
Let's come together to spread the colours of joy, health, and prosperity!
Happy Holi from all of us at Lyrus! 🎨
Lyrus LifeSciences Stabicon Life Sciences Pvt. Ltd.

Uniting Against Tuberculosis on World TB Day
On World Tuberculosis Day, we at Lyrus, a leading Pharma Contract Development and Manufacturing Organization (CDMO), join the global community in raising awareness about the ongoing battle against tuberculosis (TB), an ancient yet persistent disease that continues to impact millions of lives worldwide.
Tuberculosis remains one of the top 10 causes of death worldwide, claiming the lives of over 1.5 million people every year. Despite significant progress in the fight against TB, the disease remains a formidable challenge, particularly in low- and middle-income countries where access to proper diagnosis and treatment is often limited.
At Lyrus, we are deeply committed to supporting the development and manufacturing of innovative therapies to help turn the tide against tuberculosis. Through our collaborations with leading pharmaceutical companies, we contribute our expertise and state-of-the-art facilities to ensure the reliable production of high-quality anti-TB medications.
Our efforts not only aim to improve access to existing treatments but also pave the way for the development of new, more effective, and better-tolerated therapies. By leveraging our technical capabilities and rigorous quality standards, we strive to deliver life-saving medications that can reach patients in need, regardless of their geographic or socioeconomic circumstances.
However, the fight against tuberculosis requires a concerted effort from all stakeholders – healthcare professionals, researchers, policymakers, and communities alike. We must work together to address the social determinants of health, improve early detection and diagnosis, and ensure equitable access to treatment and care.
On this World TB Day, we reaffirm our commitment to supporting the global efforts to end the tuberculosis epidemic. Together, we can build a healthier, more equitable world where no one is left behind in the battle against this ancient scourge.
Join us in raising awareness, advocating for action, and supporting the development of innovative solutions to tackle tuberculosis. Together, we can create a future free from the burden of this preventable and curable disease.

Celebrating Happiness and Well-being on International Day of Happiness
On this International Day of Happiness, we at Lyrus take a moment to reflect on the importance of happiness and well-being in our lives and the lives of those we serve. As a leading Pharma Contract Development and Manufacturing Organization (CDMO), our mission is to contribute to advancing healthcare and improving the quality of life for people worldwide.
Happiness is not just a fleeting emotion but a fundamental aspect of human existence that profoundly impacts our physical and mental health. When we are happy and content, we are better equipped to face life's challenges, build meaningful relationships, and achieve our goals.
At Lyrus, we understand that happiness is intrinsically linked to well-being. That's why we are dedicated to developing and manufacturing high-quality pharmaceutical products that alleviate suffering, manage chronic conditions, and improve overall health outcomes. By partnering with innovators in the pharmaceutical industry, we strive to bring life-changing therapies to patients, empowering them to live happier, healthier lives.
However, happiness and well-being extend beyond physical health. We believe in fostering an environment that nurtures the emotional and professional growth of our employees. By promoting a positive work culture, encouraging work-life balance, and supporting personal development, we aim to create a workplace where our team members can thrive and fulfil their roles.
On this International Day of Happiness, we reaffirm our commitment to contributing to a happier and healthier world. Together, we can make a difference in the lives of individuals, families, and communities, one step at a time.
Let's embrace the pursuit of happiness and well-being and join forces to create a brighter future for all.

International Women's Day: March 8
At Lyrus, we are proud to celebrate International Women's Day and honour the accomplishments and contributions of women across our company and industry. Women are integral to innovation in pharma, making up significant portions of our workforce, leadership and customer base. We firmly believe in fostering a culture of diversity, equity and inclusion where women can thrive professionally. On this day, we reaffirm our commitment to empowering women through initiatives like our women's leadership program, equal pay policies, and family-friendly benefits. When women succeed, we all succeed. Let's keep pushing for progress in ensuring women have every opportunity to advance their careers and realise their full potential.
’sday Lyrus Life sciences Pvt. Ltd

Lyrus Life-Sciences Pvt. Ltd. is delighted to be a part of the upcoming DCAT Week 2024 in New York City. Elayaraja Natarajan, our Head of Research and Development, will attend the event in New York City from March 18 to March 21, 2024.

Lyrus is a DCAT member company and is very happy to connect with industry colleagues pharma leaders and explore a potential business opportunity together. We are excited to meet with our current and new clients, partners, and suppliers in the official DCAT Week hotels.

Lyrus is a pharmaceutical CDMO that offers end-to-end services, including product development and manufacturing, from concept to commercialization. We have expertise in oral solids, oral liquids, and topical formulations. Lyrus spent nearly 8 years of product development, manufacturing, and supplies to the EU, UK, and Australia along with our heritage experience of 3 decades in pharma, we filed the first US ANDA in early 2023 and ANDA approval was received recently. We are pleased to witness our first commercial shipment to the United States through our partner. We have recently expanded our product development capacity in the fields of parenteral formulations, including injectable formulations, oncology injectables, and ophthalmic formulations. We would be pleased to discuss the most recent advancements and potential collaborations to create our success story together.

If you are interested in meeting with us during DCAT Week 2024, please email us at [email protected] or [email protected]. Please also visit our website at https://lyruslife.com to find out more about us. We hope to see you soon in New York City!
Stabicon Life Sciences Pvt. Ltd. Lyrus Life sciences Pvt. Ltd

On National Science Day, we at Lyrus celebrate the spirit of scientific inquiry and innovation that drives us to create differentiated and innovative pharmaceutical products. We are inspired by the legacy of Sir C.V. Raman, who discovered the Raman effect on this day in 1928 and became the first Indian to win the Nobel Prize in Physics. His ground-breaking research opened new horizons in spectroscopy and molecular analysis.
At Lyrus, we use advanced technologies and platforms to develop and manufacture high-quality, affordable medicines for various therapeutic areas. We are proud to be part of the vibrant Indian scientific community contributing to the global advancement of science and technology. Join us in honouring the achievements of Sir C.V. Raman and all the Indian scientists who have made a difference in the world. Lyrus LifeSciences Stabicon Life Sciences Pvt. Ltd.

On World Day of Social Justice, we at Lyrus are committed to advancing social justice through our innovative and differentiated pharmaceutical products. We believe that access to quality and affordable medicines is a human right and a key driver of poverty eradication and social inclusion. That’s why we partner with global organizations and local communities to ensure our products reach those who most need them. Join us in celebrating this important day and supporting the UN’s efforts to overcome barriers and unleash opportunities for social justice. Lyrus Life sciences Pvt. Ltd Stabicon Life Sciences Pvt. Ltd.

Epilepsy impacts over 6 million people in India. On National Epilepsy Day, Lyrus reaffirms its commitment to support the development of high-quality, affordable medicines for epilepsy patients.

As a leading medicine CDMO, Lyrus strives to apply its deep expertise in formulation development and manufacturing excellence to improve access to anti-epileptic drugs. Our integrated capabilities allow us to partner with healthcare innovators to take therapies from innovative formulation development to commercial-scale production.

On this National Epilepsy Day, we renew our pledge to utilize the power of technology, collaboration and sustainable manufacturing to bring more affordable and effective treatment options to epilepsy patients in India and worldwide.

Together, we can positively impact lives by promoting early diagnosis, optimising therapy and reducing stigma around epilepsy. At Lyrus, we believe long-term partnerships and patient-centric innovations are key to overcoming the challenges posed by epilepsy.

Let us come together this National Epilepsy Day to spread awareness and make a difference. We are committed to delivering high-quality medicines that put the needs of epilepsy patients first.

WHO Video link on Epilepsy.
https://www.youtube.com/watch?v=SshVn6MUGxA&t=32s


Stabicon Life Sciences Lyrus Life sciences Pvt. Ltd

An Amazing Career Opportunity to be a part of State of the Art R&D facility awaits you!

Lyrus Life Sciences invites you to the Walk-in Interviews for “Formulation R&D” and “Analytical R&D” in Hoskote Industrial Area.

Walk-in-Interview Location:
https://lnkd.in/gKP8b_Uq
Lyrus Life Sciences Pvt Ltd, Research & Development Centre, No.54A & 54B, Hoskote Industrial Area, Hoskote, Bengaluru, Karnataka 562114.

Lyrus Life sciences Pvt. Ltd Stabicon Life Sciences Pvt. Ltd. Stabicon Life Sciences